Literature DB >> 16160826

Polymorphism of the mouse gene for the interleukin 10 receptor alpha chain (Il10ra) and its association with the autoimmune phenotype.

Zan-Mei Qi1, Jun Wang, Zheng-Rong Sun, Feng-Mao Ma, Qing-Rui Zhang, Sachiko Hirose, Yi Jiang.   

Abstract

Several studies suggest that interleukin (IL)-10 pathway is involved in murine lupus, while no linkage of IL-10 gene polymorphism to disease susceptibility has been reported in studies with lupus-prone mice. Since IL-10 functions through the specific IL-10 receptor alpha (IL-10RA) chain and the IL-10RA gene (Il10ra) is linked to the susceptibility loci of atopic dermatitis and Crohn's disease identified using mouse models, we supposed that IL-10RA might be involved in murine lupus. By flow cytometry analysis, we found that NZW mice, one of the parental strains of lupus-prone (NZBxNZW) F1 mice, express extremely low levels of IL-10RA compared with NZB mice, the other parental strain, and the healthy BALB/c and C57BL/6 mice. Sequence analyses of Il10ra cDNA of NZW mice showed multiple nucleotide mutations compared with that of NZB and C57BL/6 strains, some of which would result in amino acid substitutions in the IL-10RA protein. Lupus-prone MRL mice shared the same polymorphism with NZW. Analyses using (NZBxNZW) F1xNZB backcross mice showed that high serum levels of IgG antichromatin antibodies were regulated by a combinatorial effect of the NZW Il10ra allele and a heterozygous genotype for Tnfa microsatellite locus. Our data suggest that the polymorphic NZW-type Il10ra may be involved in the pathologic production of antichromatin antibodies and, if so, may contribute in part to the development of systemic lupus erythematosus as one susceptibility allele.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160826     DOI: 10.1007/s00251-005-0036-7

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  32 in total

1.  Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5' regulatory region.

Authors:  S D' Alfonso; M Giordano; M Mellai; M Lanceni; N Barizzone; M Marchini; R Scorza; M G Danieli; M Cappelli; P Rovere; M G Sabbadini; P Momigliano-Richiardi
Journal:  Genes Immun       Date:  2002-12       Impact factor: 2.676

2.  Interleukin-10 receptor expression in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  A P Cairns; A D Crockard; A L Bell
Journal:  Clin Exp Rheumatol       Date:  2003 Jan-Feb       Impact factor: 4.473

Review 3.  A Macintosh program for storage and analysis of experimental genetic mapping data.

Authors:  K F Manly
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

Review 4.  The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes.

Authors:  R P Donnelly; H Dickensheets; D S Finbloom
Journal:  J Interferon Cytokine Res       Date:  1999-06       Impact factor: 2.607

5.  A major determinant quantitative-trait locus responsible for atopic dermatitis-like skin lesions in NC/Nga mice is located on Chromosome 9.

Authors:  Y Kohara; K Tanabe; K Matsuoka; N Kanda; H Matsuda; H Karasuyama; H Yonekawa
Journal:  Immunogenetics       Date:  2001-02       Impact factor: 2.846

6.  Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.

Authors:  L Llorente; Y Richaud-Patin; C García-Padilla; E Claret; J Jakez-Ocampo; M H Cardiel; J Alcocer-Varela; L Grangeot-Keros; D Alarcón-Segovia; J Wijdenes; P Galanaud; D Emilie
Journal:  Arthritis Rheum       Date:  2000-08

7.  Functional regions of the mouse interleukin-10 receptor cytoplasmic domain.

Authors:  A S Ho; S H Wei; A L Mui; A Miyajima; K W Moore
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

8.  Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells.

Authors:  E S Sobel; C Mohan; L Morel; J Schiffenbauer; E K Wakeland
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

9.  Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production.

Authors:  Christoph Gasche; Paul Grundtner; Petra Zwirn; Walter Reinisch; Sarah H Shaw; Alexander Zdanov; Usha Sarma; Lynn M Williams; Brian M Foxwell; Alfred Gangl
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

Review 10.  The complex role of interleukin-10 in autoimmunity.

Authors:  Hervé Groux; Françoise Cottrez
Journal:  J Autoimmun       Date:  2003-06       Impact factor: 7.094

View more
  10 in total

1.  Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.

Authors:  H D Cui; Z M Qi; L L Yang; L Qi; N Zhang; X L Zhang; S Y Du; Y Jiang
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

2.  TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects.

Authors:  Christopher S Carlson; Patrick J Heagerty; Alex S Nord; David K Pritchard; Jane Ranchalis; Joshua M Boguch; Hangjun Duan; Thomas S Hatsukami; Stephen M Schwartz; Mark J Rieder; Deborah A Nickerson; Gail P Jarvik
Journal:  Hum Genet       Date:  2006-11-18       Impact factor: 4.132

3.  Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.

Authors:  Mary Joseph Acevedo; Jennifer S Wilder; Sharon Adams; Joie Davis; Corin Kelly; Dianne Hilligoss; Ellen Carroll; Bazetta Blacklock-Schuver; Kristen Cole; Elizabeth M Kang; Amy P Hsu; Christopher G Kanakry; Dimana Dimitrova; Jennifer A Kanakry
Journal:  Biol Blood Marrow Transplant       Date:  2019-04-12       Impact factor: 5.742

4.  Seeing the forest for the trees: using the Gene Ontology to restructure hierarchical clustering.

Authors:  Dikla Dotan-Cohen; Simon Kasif; Avraham A Melkman
Journal:  Bioinformatics       Date:  2009-06-03       Impact factor: 6.937

Review 5.  Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.

Authors:  Hui Peng; Wei Wang; Mo Zhou; Rui Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2013-05-25       Impact factor: 2.980

6.  Endogenous suppression of mast cell development and survival by IL-4 and IL-10.

Authors:  Kelly Speiran; Daniel P Bailey; Josephine Fernando; Matthew Macey; Brian Barnstein; Motunrayo Kolawole; Dana Curley; Stephanie S Watowich; Peter J Murray; Carole Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2009-02-19       Impact factor: 4.962

7.  A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.

Authors:  Hisashi Oishi; Takahito Tsubaki; Tatsuhiko Miyazaki; Masao Ono; Masato Nose; Satoru Takahashi
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

8.  Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci.

Authors:  Chiara Campo; Miguel Inacio Da Silva Filho; Niels Weinhold; Hartmut Goldschmidt; Kari Hemminki; Maximilian Merz; Asta Försti
Journal:  Neurochem Res       Date:  2016-07-16       Impact factor: 3.996

9.  An essential protective role of IL-10 in the immunological mechanism underlying resistance vs. susceptibility to lupus induction by dendritic cells and dying cells.

Authors:  Guang-Sheng Ling; H Terence Cook; Marina Botto; Yu-Lung Lau; Fang-Ping Huang
Journal:  Rheumatology (Oxford)       Date:  2011-07-04       Impact factor: 7.580

10.  Deep genome sequencing and variation analysis of 13 inbred mouse strains defines candidate phenotypic alleles, private variation and homozygous truncating mutations.

Authors:  Anthony G Doran; Kim Wong; Jonathan Flint; David J Adams; Kent W Hunter; Thomas M Keane
Journal:  Genome Biol       Date:  2016-08-01       Impact factor: 13.583

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.